Observations placeholder
Pegintron
Identifier
016899
Type of Spiritual Experience
Number of hallucinations: 23
Background
A description of the experience
Pegylated interferon alfa-2b is a treatment for hepatitis C developed by Schering-Plough, brand name is PegIntron. It was approved in January 2001.
It has also been approved as treatment for melanoma [skin cancer] with nodal involvement after surgical resection, under the brand name Sylatron in April 2011.
PEG-interferon alpha is a pegylated interferon composed of 165 amino acids. The PEG (polyethylene glycol) protects the molecule from proteolytic breakdown and increases the biological half-life of the interferon protein
On Jan, 17, 2017 9,711 people reported to have side effects when taking Pegintron. Among them, 23 people (0.24%) have Hallucinations
On Jan, 15, 2017 9,711 people reported to have side effects when taking Pegintron. Among them, 40 people (0.41%) have Death
The source of the experience
eHealthmeConcepts, symbols and science items
Concepts
Symbols
Science Items
Activities and commonsteps
Activities
Overloads
AntiviralsCancer
Hepatitis
Hepatitis virus infection
Skin diseases
Viral infection
Viral infection - Interferon drugs